Metformin modifies disparity in hepatocellular carcinoma incidence in men with type 2 diabetes but without chronic liver diseases

BACKGROUND: We assessed racial/ethnic disparity in hepatocellular carcinoma (HCC) incidence among men with type 2 diabetes (T2D) but without chronic liver diseases (CLD), and whether metformin use modified the disparity. METHODS: Study cohort: the nationwide Veterans Administration Health Care Syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chen‐Pin, Kuhn, John, Shah, Dimpy P., Schmidt, Susanne, Lam, Yui‐Wing F., MacCarthy, Daniel, Tenner, Laura, Ramirez, Amelie G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558591/
https://www.ncbi.nlm.nih.gov/pubmed/30993905
http://dx.doi.org/10.1002/cam4.2142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558591/
https://www.ncbi.nlm.nih.gov/pubmed/30993905
http://dx.doi.org/10.1002/cam4.2142

Ejemplares similares